Corvex, Inc.
MOVE- 1M
- -31.8%
Corvex, Inc. in brief
Corvex, Inc. is a listed company in the Healthcare sector, based in California, USA. It was founded in 2018. Its market value was $283 M on 30 October 2026, which makes it the 15,018th largest listed company in the world and the 2,927th largest in the USA on this site. In the year to December 2025 it had sales of $0 M and a net loss of $18 M. Its largest business segments by sales in 2025 were Segment Reporting (100%). Its shares trade under the symbol MOVE (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Corvex, Inc.
On March 19, 2026, we consummated and completed the Merger pursuant to the Merger Agreement, as further described below. Following the closing of the Merger, the Company will conduct its operations through two primary business divisions. Our AI cloud computing business specializes in GPU-accelerated infrastructure for AI workloads and our healthcare business consists of our wellness ring (formerly referred to as the Evie Ring), a wearable designed specifically for women that was launched in November 2023.
On March 19, 2026, Corvex, Inc. (formerly known as Movano Inc.), acquired Corvex Legacy Holdings, Inc. (formerly known as Corvex, Inc.), in accordance with the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026, by and among Corvex, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Company, and Corvex OpCo. Pursuant to the Merger Agreement, Merger Sub merged with and into Corvex OpCo, pursuant to which Corvex OpCo was the surviving corporation and became a wholly owned subsidiary of the Company. The Merger Agreement amended and restated in its entirety the prior merger agreement between the parties which was entered into and announced on November 6, 2025.
Corvex, Inc. timeline
- 2018
- 🏁· approximateFounded
- ✎Renamed Movano Inc.Formerly Maestro Sensors Inc..
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2021
- 🔔· approximateInitial public offering on Nasdaq
- 2026
- ✎Renamed Corvex, Inc.Formerly Movano Inc..
Events of Corvex, Inc. from the company record and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,210 (Jan 2022) · #4,794 (Dec 2022) · #4,500 (Jul 2023) · #4,092 (Jan 2024) · #2,337 (Mar 2026) · #2,811 (Aug 2026) · #2,642 (Oct 2026) · #2,931 (Oct 2026)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- 657.2×
- Price / book
- —
- Free cash flow yield
- -8.0%
- Net margin
- -4251.2%
- Operating margin
- -3604.7%
- Return on equity
- —
- Liabilities / assets
- 162.0%
- Revenue growth
- -57.4%
- R&D / revenue
- 1334.9%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $0M | -57.4% | $-16M | $-18M | -4251.2% |
| Dec 2024 | $1M | — | $-24M | $-24M | -2349.5% |
| Dec 2023 | — | — | $-30M | $-29M | — |
| Dec 2022 | — | — | $-30M | $-30M | — |
| Dec 2021 | — | — | $-20M | $-22M | — |
| Dec 2020 | — | — | $-11M | $-13M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-11M | — | — | $-21.79 | — |
| Dec 2024 | $-23M | $0M | $-23M | $-39.39 | — |
| Dec 2023 | $-26M | $0M | $-26M | $-9.51 | — |
| Dec 2022 | $-25M | $0M | $-25M | $-0.92 | $2.97 |
| Dec 2021 | $-16M | $1M | $-17M | $-0.92 | — |
| Dec 2020 | $-11M | — | — | $-6.85 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $5M (+6125.0% on a year earlier), net income $-18M. Lighter bars: fourth quarters worked out from the annual report.
SEC filings
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Nov 12, 20268-KCurrent reportResults of operations
- Oct 14, 20268-KCurrent reportMaterial agreement
- Sep 4, 20268-KCurrent reportResults of operations · Other events
- Sep 2, 20268-KCurrent reportMaterial agreement · Unregistered share sale · Regulation FD disclosure
- Aug 14, 20268-KCurrent reportResults of operations
- Aug 14, 202610-QQuarterly report · period to Jun 2026
- Jul 10, 2026S-1IPO registration
- Jul 7, 20268-KCurrent reportUnregistered share sale · Directors or officers changed · Bylaws amended · Shareholder vote · Other events
- Jun 26, 20268-KCurrent reportOther events
- Jun 16, 20268-KCurrent reportDirectors or officers changed · Regulation FD disclosure
- Jun 5, 2026DEF 14AProxy statement
Official filings of Corvex, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $0 M
- Operating income
- $-16 M
- Net income
- $-18 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $6 M
- Total liabilities
- $9 M
- Total equity
- $-3 M
As of December-2025
Top 30 institutional investors in Corvex, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Accurate Wealth Management, LLC | 498,646 | New | 1.27% | $6 M | Oct 20, 2026 |
| 2 | Weiss Asset Management LP | 258,000 | New | 0.66% | $3 M | Nov 16, 2026 |
| 3 | BlackRock, Inc. | 233,969 | +227,988 (+3811.87%) | 0.60% | $3 M | Nov 13, 2026 |
| 4 | Morgan Stanley | 199,484 | +193,903 (+3474.34%) | 0.51% | $2 M | Nov 13, 2026 |
| 5 | Vanguard Capital Management LLC | 184,558 | +162,982 (+755.39%) | 0.47% | $2 M | Nov 13, 2026 |
| 6 | Geode Capital Management, LLC | 172,873 | +153,886 (+810.48%) | 0.44% | $2 M | Nov 6, 2026 |
| 7 | State Street Corp | 94,629 | New | 0.24% | $1 M | Nov 12, 2026 |
| 8 | Vanguard Fiduciary Trust Co | 88,640 | +80,248 (+956.24%) | 0.23% | $1 M | Nov 13, 2026 |
| 9 | Northern Trust Corp | 58,978 | +32,717 (+124.58%) | 0.15% | $1 M | Nov 16, 2026 |
| 10 | Raymond James Financial Inc | 58,723 | +12,746 (+27.72%) | 0.15% | $1 M | Nov 12, 2026 |
| 11 | Millennium Management LLC | 35,813 | New | 0.09% | $0 M | Nov 16, 2026 |
| 12 | Dorsey & Whitney Trust CO LLC | 33,182 | -17,787 (-34.90%) | 0.08% | $0 M | Nov 13, 2026 |
| 13 | Peak6 LLC | 31,435 | New | 0.08% | $0 M | Nov 13, 2026 |
| 14 | Oppenheimer & Co Inc | 28,689 | New | 0.07% | $0 M | Oct 26, 2026 |
| 15 | Susquehanna International Group, LLP | 22,072 | New | 0.06% | $0 M | Nov 16, 2026 |
| 16 | UBS Group AG | 17,116 | +16,291 (+1974.67%) | 0.04% | $0 M | Nov 10, 2026 |
| 17 | Colonial Trust Advisors | 10,469 | New | 0.03% | $0 M | Nov 10, 2026 |
| 18 | Aster Capital Management (DIFC) Ltd | 8,355 | New | 0.02% | $0 M | Nov 12, 2026 |
| 19 | Vanguard Global Advisers, LLC | 6,333 | New | 0.02% | $0 M | Nov 13, 2026 |
| 20 | Tower Research Capital LLC (TRC) | 4,057 | +2,889 (+247.35%) | 0.01% | $0 M | Nov 16, 2026 |
| 21 | Barclays PLC | 3,651 | +3,468 (+1895.08%) | 0.01% | $0 M | Nov 6, 2026 |
| 22 | Clearstead Advisors, LLC | 3,140 | 0 (0.00%) | 0.01% | $0 M | Nov 6, 2026 |
| 23 | Pinnacle Financial Group, Inc. | 1,600 | — | 0.00% | $0 M | Nov 16, 2026 |
| 24 | Northwestern Mutual Wealth Management Co | 1,004 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 25 | Citigroup Inc | 306 | New | 0.00% | $0 M | Nov 4, 2026 |
Show all 30: investors 26 to 30
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Osaic Holdings, Inc. | 200 | +133 (+198.51%) | 0.00% | $0 M | Nov 12, 2026 |
| 27 | Jpmorgan Chase & Co | 142 | +53 (+59.55%) | 0.00% | $0 M | Nov 12, 2026 |
| 28 | Royal Bank Of Canada | 98 | +29 (+42.03%) | 0.00% | $0 M | Nov 16, 2026 |
| 29 | Evolution Wealth Management Inc. | 4 | 0 (0.00%) | 0.00% | $0 M | Oct 28, 2026 |
| 30 | Simplex Trading, LLC | 1 | New | 0.00% | $0 M | Nov 4, 2026 |
Mutual funds holding Corvex, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 21,576 | $0 M | 0.06% | <0.01% | +251% | Jun 30, 2026 |
| 🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc. | 6,491 | $0 M | 0.02% | 0.04% | new | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 5,250 | $0 M | 0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 4,937 | $0 M | 0.01% | <0.01% | +6.1% | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 1,558 | $0 M | <0.01% | <0.01% | +36% | May 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 1,438 | $0 M | <0.01% | <0.01% | +36% | May 31, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 346 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 7 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Corvex, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Seth DemseyCo-Chief Executive Officer, Director | Conversion | +5.48 M | — | — | 8.56 M | Form 4 |
| filed | John Adler Crystal IIICo-Chief Executive Officer, Director | Conversion | +3.35 M | — | — | 6.41 M | Form 4 |
| filed | Emily FairbairnDirector | Conversionindirect | +1.21 M | — | — | 1.21 M | Form 4 |
| filed | Seth DemseyCo-Chief Executive Officer, Director | Conversionindirect | +31,270 | — | — | 31,409 | Form 4 |
| filed | John Adler Crystal IIICo-Chief Executive Officer, Director | Conversionindirect | +708,154 | — | — | 711,321 | Form 4 |
| filed | Patrick FleuryDirector | Grant or award | +100,000 | — | — | 100,000 | Form 4 |
| filed | Christopher MorelandCFO | Grant or award | +523,211 | — | — | 523,211 | Form 4 |
| filed | Emily FairbairnDirector | Grant or award | +135,800 | — | — | 228,577 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Corvex, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2026-11-12 14:30 UTC, code LUDP, resumed 14:35 UTC
Fails to deliver
- : 971 shares at $7.22
- : 4,828 shares at $7.57
- : 1,509 shares at $8.07
- : 2,245 shares at $8.45
- : 100 shares at $8.54
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Corvex, Inc. scorecard#
Passes 0 of the 14 checks that could be worked out. Fiscal year 2025; market cap of Oct 30, 2026.
Valuation0 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
- ✗Price to sales below its peers' median657.2×Price to sales 657.2× against Healthcare's median of 3.8×.
- ✗Free cash flow yield above 5%-8.0%Free cash flow is -8.0% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth0 of 2
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-21.79 vs -39.39Diluted EPS -21.79 in fiscal 2025 against -39.39 the year before (report's currency).
- ✗Net income higher than five years earlier-$18 M-$18 M in fiscal 2025 against -$13 M in 2020.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 2
- ✗Profitable in the newest year-$18 MNet income -$18 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- –Operating margin above its peers' medianNo operating margin on file.
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health0 of 4
- ✗Short-term assets cover short-term liabilities0.6×Current ratio 0.57 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-5.2×Operating income -5.2 times interest in fiscal 2025.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-32.78Z-score -32.78 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year39.7%Diluted shares up 39.7% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Healthcare, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Corvex, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.4−57.3%100% | 1.0—100% | — | — | — | — | |
| Cost of revenue | 2.3−24.4%525% | 3.0—297% | — | — | — | — | |
| Research and development | 5.7−48.7%1326% | 11−33.7%1105% | 17−11.1%— | 19+41.5%— | 13+60.4%— | 8.4—— | |
| General and administrative | 7.9−28.2%1830% | 11−13.8%1089% | 13+11.6%— | 11+79.9%— | 6.4+133%— | 2.7—— | |
| Operating expenses | — | — | 30−2.5%— | 30+53.8%— | 20+78.3%— | 11—— | |
| Total costs and expenses | 16−36.8%3680% | 25−15.0%2491% | 30—— | — | — | — | |
| Operating income | −16—−3580% | −24—−2391% | −30—— | −30—— | −20—— | −11—— | |
| Interest expense and finance costs | 3.0—685% | — | — | 0.8−9.4%— | 0.9−12.1%— | 1.0—— | |
| Net interest income | — | — | — | 0.1—— | −2.0—— | −1.9—— | |
| Other non-operating income (expense) | −2.8−662%−642% | 0.5+21.6%48.9% | 0.4+206%— | 0.1—— | — | — | |
| Income before tax | −18—−4223% | — | — | — | — | — | |
| Net income including minority interests | — | — | — | — | −22—— | −13—— | |
| Net income attributable to shareholders | −18—−4223% | −24—−2342% | −29—— | −30—— | −22—— | −13—— | |
| Earnings per share, basic | -21.79—— | -39.39r-3.94—— | -9.51r-0.63—— | -0.92—— | -0.92—— | -6.85—— | |
| Earnings per share, diluted | -21.79—— | -39.39r-3.94—— | -9.51r-0.63—— | -0.92r-0.91—— | -0.92—— | -6.85—— | |
| Shares, weighted average (basic) | 0.8+39.6%— | 0.6r6.0−80.4%— | 3.1r46−90.7%— | 33+25.6%— | 26—— | — | |
| Shares, weighted average (diluted) | 0.8+39.6%— | 0.6r6.0−80.4%— | 3.1r46−90.7%— | 33r33+25.6%— | 26+721%— | 3.2—— | |
| Dividends per share | — | — | — | 2.97—— | — | — | |
| Balance sheet | |||||||
| Cash and cash equivalents | 2.8−64.2%50.5% | 7.9+29.2%69.8% | 6.1−43.1%64.9% | 11−39.1%81.2% | 18+210%48.7% | 5.7—80.6% | |
| Short-term investments | — | — | — | — | 16r16—43.9% | — | |
| Inventory | 1.8−13.7%31.5% | 2.0+83.7%18.1% | 1.1—11.8% | — | — | — | |
| Other current assets | 0.4r0.2+8.8%7.0% | 0.4−18.1%3.2% | 0.4+9.1%4.7% | 0.4r0.5−68.8%3.1% | 1.3+87.6%3.6% | 0.7—9.8% | |
| Current assets | 5.0−52.0%89.1% | 10+21.9%91.8% | 8.5−26.8%90.5% | 12−66.8%87.9% | 35+408%96.7% | 6.9—97.4% | |
| Property, plant and equipment | 0.1−52.6%1.8% | 0.2−37.7%1.9% | 0.3−22.8%3.6% | 0.4−16.3%3.3% | 0.5+1292%1.5% | 0.0—0.5% | |
| Right-of-use (leased) assets | 0.4−30.8%7.4% | 0.6r0.0+242815%5.3% | 0.0r0.2−99.9%0.0% | 0.4—2.9% | — | — | |
| Total assets | 5.6−50.5%100% | 11+20.2%100% | 9.4−28.9%100% | 13−63.5%100% | 36+412%100% | 7.1—100% | |
| Accounts payable | 3.5+72.5%62.1% | 2.0−35.3%17.8% | 3.1+460%33.1% | 0.6+79.1%4.2% | 0.3+26.4%0.9% | 0.2—3.5% | |
| Current liabilities | 8.8+156%157% | 3.4−41.6%30.4% | 5.9+18.5%62.6% | 5.0+54.7%37.6% | 3.2+177%8.9% | 1.2—16.4% | |
| Lease liabilities (non-current) | 0.3−46.8%4.8% | 0.5r0.0+3346567%4.4% | 0.0r0.0—0.0% | — | — | — | |
| Non-current liabilities | 0.3−48.7%4.8% | 0.5+612%4.6% | 0.1−79.1%0.8% | 0.4+10.4%2.6% | 0.3−97.7%0.9% | 14—197% | |
| Total liabilities | 9.1+129%162% | 4.0−33.6%35.0% | 6.0+12.1%63.4% | 5.3+50.7%40.2% | 3.5−76.7%9.7% | 15—214% | |
| Retained earnings | −166—−2971% | −148—−1308% | −124—−1320% | −95—−718% | −65—−179% | −41—−577% | |
| Shareholders' equity | −3.5−147%−62.0% | 7.4+113%65.0% | 3.4−56.4%36.6% | 7.9−75.8%59.8% | 33—90.3% | −41—−577% | |
| Total equity | — | — | — | — | 33—90.3% | — | |
| Total liabilities and equity | 5.6−50.5%100% | 11+20.2%100% | 9.4−28.9%100% | 13−63.5%100% | 36+412%100% | 7.1—100% | |
| Shares outstanding | 1.2r0.9+79.6%— | 0.7r6.8−81.6%— | 3.7r56−88.9%— | 34r33+2.7%— | 33+413%— | 6.4—— | |
| Cash-flow statement | |||||||
| Depreciation and amortization | 0.1−10.2%34.4% | 0.2+5.1%16.4% | 0.2+7.5%— | 0.1+98.6%— | 0.1+469%— | 0.0—— | |
| Share-based compensation | 2.9−9.7%673% | 3.2+8.2%318% | 3.0−3.7%— | 3.1+67.0%— | 1.9+316%— | 0.4—— | |
| Cash from operating activities | −11—−2602% | −23—−2224% | −26—— | −25—— | −16—— | −11—— | |
| Capital expenditure | — | −0.0—−0.8% | −0.1—— | −0.1—— | −0.6—— | — | |
| Cash from investing activities | — | −0.0—−0.8% | −0.1−100%— | 16—— | −17—— | — | |
| Debt issued | 1.5—346% | — | — | — | — | 12—— | |
| Shares issued | 1.6−4.4%371% | 1.7−47.5%166% | 3.2+43.6%— | 2.2+2836%— | 0.1−88.8%— | 0.7—— | |
| Cash from financing activities | 6.2−74.5%1430% | 24+12.6%2401% | 22+855%— | 2.3−95.0%— | 45+271%— | 12—— | |
| Change in cash | — | — | — | −6.9−158%— | 12—— | — | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 9.3+1767%100% | 5.0+6128%100% | 3.8+3590%100% | 0.5+148%100% | 0.0*−60.4%100% | 0.1+60.0%100% | 0.1+348%100% | 0.2−75.8%100% | 0.1*—100% | 0.1—100% | 0.0—100% | 0.9—100% | — | |
| Cost of revenue | — | — | — | — | 1.0*+74.4%2248% | 0.3−66.9%350% | 0.4−4.7%351% | 0.6−47.2%312% | 0.6*—511% | 0.8—1690% | 0.4—1652% | 1.2—143% | — | |
| Research and development | 4.3−38.0%46.0% | 1.3+13.1%26.5% | 1.4−2.5%35.9% | 0.8−65.2%161% | 0.8*−60.4%1795% | 1.2−65.7%1458% | 1.4−51.8%1360% | 2.4r2.4−18.1%1148% | 2.0*−37.4%1799% | 3.4—6808% | 2.9—12639% | 2.9—339% | 3.2*—— | |
| Selling, general and administrative | — | — | — | — | — | — | — | — | — | 3.2—6360% | — | — | — | |
| Selling and marketing | — | 0.8—16.9% | 0.7—19.5% | 0.3−60.2%59.6% | — | — | — | 0.8—370% | — | — | — | — | — | |
| General and administrative | 33+393%354% | 15+1111%298% | 12+657%319% | 3.4+107%665% | 2.7*+19.7%6089% | 1.2−61.5%1531% | 1.6−48.6%1553% | 1.6r2.4−34.6%795% | 2.2*−20.9%2017% | 3.2—6360% | 3.1—13522% | 2.5—294% | 2.8*—— | |
| Operating expenses | — | — | — | — | — | — | — | — | — | — | — | — | 6.0*—— | |
| Total costs and expenses | 51+215%549% | 22+739%450% | 19+465%500% | 5.4−1.6%1050% | 4.5*−7.2%10132% | 2.7−64.0%3339% | 3.4−47.4%3265% | 5.4−17.6%2643% | 4.8*—4327% | 7.4—14858% | 6.4—27813% | 6.6—775% | — | |
| Operating income | −42—−449% | −17—−350% | −15—−400% | −4.8—−950% | −4.4*—−10032% | −2.6—−3239% | −3.3—−3165% | −5.2—−2543% | −4.7*—−4227% | −7.4—−14758% | −6.4—−27813% | −5.8—−675% | −6.0*—— | |
| Interest and finance income | — | — | — | — | — | — | — | — | — | — | 0.2—900% | 0.0—4.0% | — | |
| Interest expense and finance costs | 1.7—17.9% | 0*−100%0.0% | 0.0—0.8% | 0.2—34.9% | 1.5*—3323% | 1.5—1879% | — | — | — | — | — | — | — | |
| Other non-operating income (expense) | 0.8—8.5% | −0.1—−1.6% | 2.5+6960%65.0% | −0.2−363%−31.0% | −1.4*−1993%−3270% | −1.4−908%−1798% | 0.0−83.1%34.0% | 0.1+76.5%29.1% | 0.1*+15.2%68.5% | 0.2—356% | 0.2—900% | 0.0—4.0% | 0.1*—— | |
| Income before tax | −41—−440% | −18—−352% | −13—−335% | −5.0—−981% | −5.9*—−13302% | −4.0—−5036% | −3.2—−3131% | −5.2—−2514% | — | — | — | — | — | |
| Income tax | — | — | 0.0—0.5% | — | — | — | — | — | — | 0—0.0% | — | — | — | |
| Net income attributable to shareholders | −41—−441% | −18—−352% | −13—−336% | −5.0—−981% | −5.9*—−13302% | −4.0—−5036% | −3.2—−3131% | −5.2—−2514% | −4.6*—−4159% | −7.2—−14402% | −6.2—−26913% | −5.7—−671% | −6.0*—— | |
| Earnings per share, basic | — | -0.60—— | -5.12—— | -3.13—— | — | -3.49r-4.73—— | -3.05r-0.41—— | -5.35r-0.73—— | — | -10.56r-1.06—— | -0.93r-0.06—— | -1.53r-0.10—— | — | |
| Earnings per share, diluted | — | -0.60—— | -5.12—— | -3.13—— | — | -3.49r-4.73—— | -3.05r-0.41—— | -5.35r-0.73—— | — | -10.56r-1.06—— | -0.93r-0.06—— | -1.53r-0.10—— | — | |
| Shares, weighted average (basic) | 29+2410%— | 29+2410%— | 2.5+137%— | 1.6+68.4%— | — | 1.2r0.9+69.6%— | 1.1r7.8−84.1%— | 1.0r7.1−74.1%— | — | 0.7r6.8—— | 6.6r100—— | 3.7r56—— | — | |
| Shares, weighted average (diluted) | 29+2410%— | 29+2410%— | 2.5+137%— | 1.6+68.4%— | — | 1.2r0.9+69.6%— | 1.1r7.8−84.1%— | 1.0r7.1−74.1%— | — | 0.7r6.8—— | 6.6r100—— | 3.7r56—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 42—6.7% | 42+1999%6.7% | 22+929%3.6% | 29+573%4.9% | 2.8−64.2%50.5% | 2.0−82.3%36.0% | 2.1−87.5%37.3% | 4.4+103%56.1% | 7.9+29.2%69.8% | 11—74.8% | 17—81.0% | 2.1—41.8% | 6.1—64.9% | |
| Receivables | 1.7—0.3% | 1.7—0.3% | 1.6—0.3% | 1.5—0.2% | — | — | — | — | — | — | — | — | — | |
| Inventory | — | — | — | 1.8−21.3%0.3% | 1.8−13.7%31.5% | 2.5+21.6%44.5% | 2.5+38.5%43.8% | 2.3+112%29.1% | 2.0+83.7%18.1% | 2.0—13.5% | 1.8—8.6% | 1.1—20.7% | 1.1—11.8% | |
| Other current assets | 5.5—0.9% | 5.5+1900%0.9% | 5.0+2002%0.8% | 5.3+2052%0.9% | 0.4r0.2+8.8%7.0% | 0.3−40.9%5.0% | 0.2−69.3%4.2% | 0.2−24.5%3.2% | 0.4−18.1%3.2% | 0.5—3.1% | 0.8—3.7% | 0.3—6.3% | 0.4—4.7% | |
| Current assets | 50—8.0% | 50+926%8.0% | 28+478%4.7% | 38+448%6.3% | 5.0−52.0%89.1% | 4.9−65.3%87.5% | 4.9−75.2%86.3% | 6.9+55.6%89.0% | 10+21.9%91.8% | 14—93.0% | 20—94.5% | 4.4—86.6% | 8.5—90.5% | |
| Property, plant and equipment | 39—6.2% | 39+30206%6.2% | 31+19883%5.2% | 29+15701%4.8% | 0.1−52.6%1.8% | 0.1−45.6%2.3% | 0.2−42.3%2.8% | 0.2−38.5%2.4% | 0.2−37.7%1.9% | 0.2—1.6% | 0.3—1.3% | 0.3—5.8% | 0.3—3.6% | |
| Right-of-use (leased) assets | 4.7—0.7% | 4.7+909%0.7% | 5.3+939%0.9% | 3.8+583%0.6% | 0.4−30.8%7.4% | 0.5−27.2%8.3% | 0.5−25.0%9.0% | 0.6+191%7.1% | 0.6r0.0+242815%5.3% | 0.6—4.2% | 0.7—3.3% | 0.2—3.7% | 0.0r0.2—0.0% | |
| Goodwill | 519—82.7% | 519—82.7% | 519—86.7% | 1.1r518—0.2% | — | — | — | — | — | — | — | — | — | |
| Other intangible assets | 15—2.3% | 15—2.3% | 15—2.5% | 15—2.5% | — | — | — | — | — | — | — | — | — | |
| Total assets | 628—100% | 628+11196%100% | 599+10489%100% | 604+7684%100% | 5.6−50.5%100% | 5.6−63.1%100% | 5.7−72.8%100% | 7.8+51.2%100% | 11+20.2%100% | 15—100% | 21—100% | 5.1—100% | 9.4—100% | |
| Accounts payable | 3.9—0.6% | 3.9+34.5%0.6% | 3.9+38.7%0.6% | 3.7+45.3%0.6% | 3.5+72.5%62.1% | 2.9+51.5%51.7% | 2.8+81.5%49.3% | 2.5−36.5%32.5% | 2.0−35.3%17.8% | 1.9—12.6% | 1.5—7.4% | 4.0—77.4% | 3.1—33.1% | |
| Current liabilities | 16—2.6% | 16+133%2.6% | 16+332%2.6% | 18+334%2.9% | 8.8+156%157% | 6.9+63.6%125% | 3.6+6.0%64.1% | 4.1−38.0%52.4% | 3.4−41.6%30.4% | 4.2—28.1% | 3.4—16.4% | 6.6—128% | 5.9—62.6% | |
| Lease liabilities (non-current) | 2.2—0.4% | 2.2+577%0.4% | 2.9+649%0.5% | 2.1+370%0.3% | 0.3−46.8%4.8% | 0.3−40.9%5.9% | 0.4−34.7%6.8% | 0.4+22150%5.7% | 0.5r0.0+3346567%4.4% | 0.6—3.7% | 0.6—2.8% | 0.0—0.0% | 0.0r0.0—0.0% | |
| Non-current liabilities | 13—2.1% | 13+3869%2.1% | 10+2524%1.7% | 11+2253%1.8% | 0.3−48.7%4.8% | 0.3−43.1%6.0% | 0.4−36.8%7.0% | 0.5+943%5.9% | 0.5+612%4.6% | 0.6—3.9% | 0.6—3.0% | 0.0—0.9% | 0.1—0.8% | |
| Total liabilities | 29—4.7% | 29+304%4.7% | 26+548%4.4% | 28+528%4.7% | 9.1+129%162% | 7.3+50.7%131% | 4.0−0.6%71.1% | 4.5−31.5%58.4% | 4.0−33.6%35.0% | 4.8—32.0% | 4.0—19.4% | 6.6—129% | 6.0—63.4% | |
| Retained earnings | −202—−32.1% | −202—−32.1% | −184—−30.7% | −171—−28.4% | −166—−2971% | −161—−2889% | −157—−2765% | −153—−1974% | −148—−1308% | −143—−952% | −136—−654% | −130—−2534% | −124—−1320% | |
| Shareholders' equity | 598—95.3% | 598—95.3% | 573+34918%95.6% | 576r576+17712%95.3% | −3.5−147%−62.0% | −1.7−117%−30.6% | 1.6−90.2%28.9% | 3.2—41.6% | 7.4+113%65.0% | 10—68.0% | 17—80.6% | −1.5—−28.8% | 3.4—36.6% | |
| Total liabilities and equity | 628—100% | 628+11196%100% | 599+10489%100% | 604+7684%100% | 5.6−50.5%100% | 5.6−63.1%100% | 5.7−72.8%100% | 7.8+51.2%100% | 11+20.2%100% | 15—100% | 21—100% | 5.1—100% | 9.4—100% | |
| Shares outstanding | 39—— | 39+4580%— | 2.1−75.2%— | 1.9−72.7%— | 1.2r0.9+79.6%— | 0.8−87.4%— | 8.3−91.6%— | 7.0−87.5%— | 0.7r6.8−81.6%— | 6.6—— | 99—— | 56—— | 3.7r56—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 5.9+3617%63.7% | 2.9+10286%58.4% | 2.7+4679%70.4% | 0.3+758%63.9% | 0.0*−2.6%84.1% | 0.0−6.7%35.0% | 0.1+107%54.4% | 0.0−26.9%18.4% | 0.0*−5.0%34.2% | 0.0—60.0% | 0.0—117% | 0.1—6.1% | 0.0*—— | |
| Share-based compensation | 24+1256%257% | 11+1533%227% | 9.4*+3655%247% | 2.2+628%427% | 1.1*+116%2598% | 0.7r0.1+29.4%864% | 0.3−83.8%243% | 0.3−51.5%145% | 0.5*−27.2%477% | 0.5—1068% | 1.5—6713% | 0.6—72.4% | 0.7*—— | |
| Cash from operating activities | −19—−202% | −7.0*—−141% | −5.3*—−139% | −4.3—−841% | −2.3*—−5136% | −1.6*—−2011% | −3.1*—−3006% | −4.3—−2089% | −4.6*—−4104% | −5.7*—−11350% | −8.2*—−35530% | −4.1—−485% | −5.2*—— | |
| Capital expenditure | — | −9.5*—−191% | −0.2*—−6.4% | −6.2—−1223% | — | — | — | — | −0.0*—−4.5% | — | 0*—0.0% | −0.0—−0.7% | −0.0*—— | |
| Acquisitions, net of cash acquired | — | 0*—0.0% | −0.0*—−0.0% | −37—−7192% | — | — | — | — | — | — | — | — | — | |
| Cash from investing activities | — | −9.8*—−196% | −0.7*—−17.2% | 30—5969% | — | — | — | — | −0.0*—−4.5% | 0.0*—6.0% | 0*—0.0% | −0.0—−0.7% | −0.0*—— | |
| Debt issued | — | — | — | — | 0*—0.0% | — | — | — | — | — | — | — | — | |
| Shares issued | — | — | — | — | 0*−100%0.0% | 0*−100%0.0% | 0.8*+324%823% | 0.8+362%368% | 1.2*+738%1072% | 0.2—400% | 0.2—870% | 0.2—19.2% | 0.1*—— | |
| Cash from financing activities | 40+820%423% | 38*+2420%759% | −1.7*−301%−44.9% | 0.4−53.8%68.6% | 3.1*+159%7016% | 1.5*+1874%1875% | 0.8*−96.3%823% | 0.8+362%368% | 1.2*−67.9%1072% | 0.1*—152% | 23*—99543% | 0.2—19.2% | 3.7*—— | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Corvex, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue. Lines can overlap (a total and its parts), so they are not added up.
Business segments
- Segment Reporting$0 M100%—
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where Corvex, Inc. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 3 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office2 subsidiaries | — |
| 🇮🇪 Ireland | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Events at Corvex, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 3 · Auditor changed 1 · Change in control 1 · Directors and officers 4 · Material agreement 5 · New debt 1 · Unregistered share sale 4 · Shareholder rights changed 2 · Bylaws or fiscal year changed 4 · Shareholder vote 3 · Results announced 6
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Directors and officersUnregistered share saleBylaws or fiscal year changedShareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Auditor changed | 8-K | |
| Delisting noticeDirectors and officersMaterial agreementUnregistered share saleShareholder rights changedBylaws or fiscal year changed | 8-K | |
| Results announced | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Change in controlMaterial agreementNew debtUnregistered share saleBylaws or fiscal year changed | 8-K | |
| Material agreement | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Delisting notice | 8-K | |
| Shareholder vote | 8-K | |
| Delisting notice | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
1 acquisitions · 2 private funding rounds before listing
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| Merger Agreement | Nov 2025 | — | — | — | Annual report |
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2026 | $33 M | Private placement after listing | $10 to $50 million | 26 | equity | SEC |
| Apr 2024 | $24 M | Private placement after listing | $10 to $50 million | 185 | equity, options | SEC |
| Mar 2019 | $10 M | No. 2 | $10 to $50 million | 183 | equity, options | SEC |
| Mar 2018 | $6 M | No. 1 | $2 to $10 million | 22 | equity, options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Corvex, Inc.#
2 labor condition applications certified in fiscal 2025 for 2 positions, at a median wage of $160 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Manager, Quality SystemsQuality Control Systems Managers | 1 | $136 K |
| Sr. Embedded Firmware EngineerSoftware Developers | 1 | $185 K |
Where: Pleasanton, CA 2
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2025 | 2 | 2 | $160 K | 2 |
| FY2023 | 1 | 1 | $185 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Movano Inc
How Corvex, Inc. compares in Healthcare
- Market cap$283 M · higher than 38% of 2,013
- Revenue$0 M · higher than 9% of 1,795
- Revenue growth-57.4% · higher than 8% of 1,003
- Price / sales657.2× · lower than 0% of 1,071
- FCF yield-8.0% · higher than 45% of 835
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Corvex, Inc.🇺🇸 | $283 M | — | — | -57.4% |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Corvex, Inc.? Verify and update this profile — free
Show Corvex, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.